Page 71 - IJB-6-4
P. 71
Soman and Vijayavenkataraman
size, pore geometry, and the surface contact area the disease [107,108] . A few examples of disease
are the deciding factors for successful growth of modeling in cardiac, neurodegenerative and
functional ovarian tissue. Stem cells isolated from neurodevelopmental diseases and oncology are
the patient’s own ovarian tissue can serve as the briefly discussed in the following sections.
starting material to bioprint the functional ovary.
4.3.1 Cardiac diseases
4.2.3 Thyroid gland replacement in Cardiovascular diseases remain the leading cause
thyrectomized patients of death in the developed world, accounting for
Bioprinting of a functional vascularized mouse more than 30% of all deaths. Collection of cardiac
thyroid gland construct from embryonic tissue tissue from patients with disease causing mutations
spheroids was reported by Bulenova et al. in for genetic studies and functional analyses is a
2017 [103] . Self-assembling thyroid spheres, highly invasive procedure. iPSCs derived from the
thyrocytes, and endothelial cells suspended in peripheral tissues of patients with disease specific
collagen gel were used for bioprinting the thyroid mutations are a valuable tool to study the cardiac
gland. The bioprinted construct was implanted in pathophysiology and drug development. Cardiac
a hypothyroid mouse and it could normalize the tissues were biofabricated using hydrogels
blood thyroxine levels and body temperature in and supporting cells such as cardiomyocytes,
the tested mice. Bioprinting of functional mouse endothelial cells, smooth muscle cells, and
thyroid gland tissue represents a major advance fibroblasts [109,110] . The cells were cocultured and
in bioprinting technology and organ regeneration engineered to resemble their natural physiological
research. In March 2019, NASA announced a microenvironment and recapitulate coordinated
plan for bioprinting thyroid gland in international contractile and electrophysiological interactions
space station to study the effect of microgravity on with the ECM and heterogeneous cell types that
organs [104] . make up the myocardial tissue environment [111] .
The iPSC-derived cardiac cells were successfully
4.3 Bioprinted iPSCs in disease modeling used to model cardiac diseases such as dilated
The most advantageous aspect of using induced cardiomyopathy and myocardial infarction [112] .
pluripotent cells in clinics is the ability of These disease models help identifying the cellular
reprogramming of autologous cells taken directly phenotypes critical to cardiac pathology [113,114] .
from patients. At present, the majority of disease The microfluidic organ-on-chip methods were
modeling studies makes use of the traditional also developed to evaluate the vascular perfusion
2D cultures. Any monogenic or polygenic in cardiac tissue. The tissue composition and
disease conditions can be re-created in a cell architecture of the in vitro 3D microdevice can
culture system [83] . While 2D cultures are good be precisely defined using microfabrication
[115-117]
to understand the molecular level interactions, methods . The iPSC and embryonic stem
they possess several limitations including lack cell derived organ-on-chip systems are being used
of heterogenic cell environment and the cell for modeling a wide range of diseases, including
to cell communication cues [105] . The disease dilated cardiomyopathy, kidney glomerular injury,
[118,119]
progression hugely depends on the extracellular and wound healing .
matrix (ECM) mechanics and the cell to cell 4.3.2 Neurodegenerative and
interactions [106] . Cellular phenotypes and the neurodevelopmental diseases
non-cell autonomous disease pathogenesis 4.3.2.1 Alzheimer’s disease (AD)
require mimicking the disease conditions in
a more realistic 3D environment. 3D disease AD is a progressive neurodegenerative disorder
models would help in understanding the disease characterized by loss of cognition and disruption
mechanism in detail in the early stages of of basic functions, such as swallowing, walking,
International Journal of Bioprinting (2020)–Volume 6, Issue 4 67

